These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
172 related articles for article (PubMed ID: 39297018)
1. Comprehensive Analysis of the Mechanism of Anoikis in Hepatocellular Carcinoma. Li D; Bao Q; Ren S; Ding H; Guo C; Gao K; Wan J; Wang Y; Zhu M; Xiong Y Genet Res (Camb); 2024; 2024():8217215. PubMed ID: 39297018 [TBL] [Abstract][Full Text] [Related]
2. Anoikis-related lncRNA signature predicts prognosis and is associated with immune infiltration in hepatocellular carcinoma. Zhu J; Zhao W; Yang J; Liu C; Wang Y; Zhao H Anticancer Drugs; 2024 Jun; 35(5):466-480. PubMed ID: 38507233 [TBL] [Abstract][Full Text] [Related]
3. Six-long non-coding RNA signature predicts recurrence-free survival in hepatocellular carcinoma. Gu JX; Zhang X; Miao RC; Xiang XH; Fu YN; Zhang JY; Liu C; Qu K World J Gastroenterol; 2019 Jan; 25(2):220-232. PubMed ID: 30670911 [TBL] [Abstract][Full Text] [Related]
4. Identification of Anoikis-Related Subgroups and Prognosis Model in Liver Hepatocellular Carcinoma. Chen Y; Huang W; Ouyang J; Wang J; Xie Z Int J Mol Sci; 2023 Feb; 24(3):. PubMed ID: 36769187 [TBL] [Abstract][Full Text] [Related]
5. Identification and Validation of a Novel Six-Gene Expression Signature for Predicting Hepatocellular Carcinoma Prognosis. Yan Z; He M; He L; Wei L; Zhang Y Front Immunol; 2021; 12():723271. PubMed ID: 34925311 [TBL] [Abstract][Full Text] [Related]
6. Comprehensive analysis and experimental verification of the mechanism of anoikis related genes in pancreatic cancer. Bao Q; Li D; Yang X; Ren S; Ding H; Guo C; Wan J; Xiong Y; Zhu M; Wang Y Heliyon; 2024 Aug; 10(16):e36234. PubMed ID: 39253230 [TBL] [Abstract][Full Text] [Related]
7. Mitochondrial-Related Transcriptome Feature Correlates with Prognosis, Vascular Invasion, Tumor Microenvironment, and Treatment Response in Hepatocellular Carcinoma. Wang Y; Song F; Zhang X; Yang C Oxid Med Cell Longev; 2022; 2022():1592905. PubMed ID: 35535359 [TBL] [Abstract][Full Text] [Related]
8. Development and validation of a robust epithelial-mesenchymal transition (EMT)-related prognostic signature for hepatocellular carcinoma. Chen S; Zhao E Clin Res Hepatol Gastroenterol; 2021 Sep; 45(5):101587. PubMed ID: 33662631 [TBL] [Abstract][Full Text] [Related]
9. Fatty acid metabolism affects hepatocellular carcinoma progression via the PPAR-γ signaling pathway and fatty acid β-oxidation. Feng W; Liang J; Xu B; Huang L; Xu Q; Chen D; Lai J; Chen J Int Immunopharmacol; 2024 Nov; 141():112917. PubMed ID: 39137630 [TBL] [Abstract][Full Text] [Related]
10. A Cuproptosis-Related LncRNA Risk Model for Predicting Prognosis and Immunotherapeutic Efficacy in Patients with Hepatocellular Carcinoma. Wang S; Bai H; Fei S; Miao B Biochem Genet; 2024 Jun; 62(3):2332-2351. PubMed ID: 37898914 [TBL] [Abstract][Full Text] [Related]
11. Anoikis-related genes in breast cancer patients: reliable biomarker of prognosis. Tang M; Rong Y; Li X; Pan H; Tao P; Wu Z; Liu S; Tang R; Liu Z; Cai H BMC Cancer; 2024 Sep; 24(1):1163. PubMed ID: 39300389 [TBL] [Abstract][Full Text] [Related]
12. Identification of PANoptosis-related subtypes, construction of a prognosis signature, and tumor microenvironment landscape of hepatocellular carcinoma using bioinformatic analysis and experimental verification. Ouyang G; Li Q; Wei Y; Dai W; Deng H; Liu Y; Li J; Li M; Luo S; Li S; Liang Y; Pan G; Yang J; Gan T Front Immunol; 2024; 15():1323199. PubMed ID: 38742112 [TBL] [Abstract][Full Text] [Related]
13. Development and validation of multi-omic prognostic signature of anoikis-related genes in liver hepatocellular carcinoma. Ding D; Wang D; Qin Y Medicine (Baltimore); 2023 Nov; 102(46):e36190. PubMed ID: 37986299 [TBL] [Abstract][Full Text] [Related]
14. A Five-Gene Signature for Recurrence Prediction of Hepatocellular Carcinoma Patients. Wang Z; Zhang N; Lv J; Ma C; Gu J; Du Y; Qiu Y; Zhang Z; Li M; Jiang Y; Zhao J; Du H; Zhang Z; Lu W; Zhang Y Biomed Res Int; 2020; 2020():4037639. PubMed ID: 33163533 [TBL] [Abstract][Full Text] [Related]
15. Comprehensive analyses of competing endogenous RNA networks reveal potential biomarkers for predicting hepatocellular carcinoma recurrence. Yan P; Huang Z; Mou T; Luo Y; Liu Y; Zhou B; Cao Z; Wu Z BMC Cancer; 2021 Apr; 21(1):436. PubMed ID: 33879119 [TBL] [Abstract][Full Text] [Related]
16. Exploring novel independent prognostic biomarkers for hepatocellular carcinoma based on TCGA and GEO databases. Hou M Medicine (Baltimore); 2022 Oct; 101(43):e31376. PubMed ID: 36316888 [TBL] [Abstract][Full Text] [Related]
17. Comprehensive analysis of immune-related gene signature based on ssGSEA algorithms in the prognosis and immune landscape of hepatocellular carcinoma. Wang L; Wang L; He P Front Genet; 2022; 13():1064432. PubMed ID: 36568383 [No Abstract] [Full Text] [Related]
18. Identification of anoikis related subtypes and construction of prognostic model in hepatocellular carcinoma. Fang W; Chen Z Cell Mol Biol (Noisy-le-grand); 2023 Sep; 69(9):219-228. PubMed ID: 37807308 [TBL] [Abstract][Full Text] [Related]
19. ANXA5: A Key Regulator of Immune Cell Infiltration in Hepatocellular Carcinoma. Wang W; Liu D; Yao J; Yuan Z; Yan L; Cao B Med Sci Monit; 2024 Jun; 30():e943523. PubMed ID: 38824386 [TBL] [Abstract][Full Text] [Related]
20. A hypoxia-related signature for clinically predicting diagnosis, prognosis and immune microenvironment of hepatocellular carcinoma patients. Zhang B; Tang B; Gao J; Li J; Kong L; Qin L J Transl Med; 2020 Sep; 18(1):342. PubMed ID: 32887635 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]